IP Status: Patent Application Filed / Pending

Screenshot 2026-08-30 at 8.39.24 AM
Off-the-Shelf Allogeneic CAR γδ T-Cell Platform
Screenshot 2026-08-21 at 12.52.53 AM
Modulating the Tumor Immune Microenvironment via Targeting Regulatory Cells (TREGS) with Chimeric Antigen Receptor (CAR) T Cell Therapy

Opportunity Filters

IP Status
Development Stage
Technology Area
Therapeutic Area
Opportunity Type

Request Information

Subject *
Message *